mizoribin monophosph map specify inhibitor cellular inosinemonophosph dehydrogenase mph enzyme catalog ratelimit step de novo gain nucleotide biosynthesis highly potent antagonist block provider b lymphocyte use pathway synthesis almost excess present studi investing bail directly inhibit human rna cap he protein harbor triphosphate guanylyltransferas active involve cap structure found end eukaryotic mra critic splice capproxim intro transport nucleus cytoplasm static translate bochum studi provide first insight format catalog present active appear rel affect inhibit india main target inhibit kinen reveal noncompetit like target allotted site also impair mra live cell could account global meghan action therapeutic agent together clearly demons inhibit vitro impair cellular 